These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6063424)
1. [Relationship between chemical structure and pharmacologic activity of several new monoamine oxidase inhibitors]. Boissier JR; Dumont C; Forest J Therapie; 1967; 22(2):367-73. PubMed ID: 6063424 [No Abstract] [Full Text] [Related]
2. Structure-activity relationship studies of neuronal monoamine uptake inhibition of pyridylallylamines. Singh P Indian J Biochem Biophys; 1984 Dec; 21(6):406-8. PubMed ID: 6545533 [No Abstract] [Full Text] [Related]
3. [Structure-action relations of monoamine oxidase inhibitors]. Matthies H; Fähse C; Lietz W; Jassmann E Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162 [No Abstract] [Full Text] [Related]
4. [The importance of the chemical structure of monoamine oxidase inhibitors for their effect on the gamma-aminobutyric acid content of the rat brain]. Matthies H; Popov N Acta Biol Med Ger; 1967; 18(5):617-24. PubMed ID: 5589667 [No Abstract] [Full Text] [Related]
6. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain]. Musialkovskaia AA Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054 [No Abstract] [Full Text] [Related]
9. Monoamine oxidase activity in the testis and epididymis of the rat. Penttilä A; Kormano M Ann Med Exp Biol Fenn; 1968; 46(4):557-63. PubMed ID: 5731568 [No Abstract] [Full Text] [Related]
10. Inactivation of cytochrome P-450 and monoamine oxidase by cyclopropylamines. Tullman RH; Hanzlik RP Drug Metab Rev; 1984; 15(5-6):1163-82. PubMed ID: 6396055 [No Abstract] [Full Text] [Related]
11. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile. Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929 [TBL] [Abstract][Full Text] [Related]
13. [Behavior of circulating and tissue eosinophils in rats after administration of reserpine associated with serotonin antagonists and after inhibition of monoamine oxidase activity]. Capelli A; Jasonni V; Piccaluga A G Clin Med; 1967 Jun; 48(6):645-55. PubMed ID: 5614475 [No Abstract] [Full Text] [Related]
15. [Pharmacologic prevention of fibrillation in acute ischemia of the heart and the dynamics of electrolytes]. Popova NK; Ivashkevich EI Biull Eksp Biol Med; 1965 May; 59(5):64-7. PubMed ID: 5880812 [No Abstract] [Full Text] [Related]
16. Action of reserpine and monoamine oxidase inhibitors on the urinary excretion of catecholamines in the rat. BICKEL MH; CARPI A; BOVET D Helv Physiol Pharmacol Acta; 1961; 19():279-84. PubMed ID: 13868969 [No Abstract] [Full Text] [Related]
17. [Pharmacologic properties of several derivatives of 2-methyl-3-carboxy-4,5,6,7-tetrahydroindole]. Shadurskaia SK; Khomenko AI; Nekrashevich AI Farmakol Toksikol; 1977; 40(2):177-81. PubMed ID: 852558 [No Abstract] [Full Text] [Related]